The competition for making the first vaccine for Lyme disease in decades has gotten mixed up in the same problem that the work on the coronavirus vaccine experienced - uncertainty from the clinical trial side. Pfizer and Valneva, two pharmaceutical companies, have just made known the results of their test on the Lyme vaccine. It was not a clear positive or negative result, yet the vaccine was effective by more than 70%. The trouble is not with the effectiveness but with the absence of data. There were not enough individuals who gathered Lyme disease during the research, which resulted in the impossibility of making statistically sound conclusions. This situation is similar to the time of initial virus vaccine trials when data clarity and regulatory decisions were affected by the changes in the infection rates.

Trial Uncertainty Similar to COVID-Times Showing up Again When it was the time of COVID-19, people creating vaccines faced hard times quite similar to these - changes in the pattern of infections taking place quickly, normally deciding on the results of the trial. A low number of cases as in the Lyme vaccine trial, which is good for health, creates complexity in the validation of the scientific model.

On the other hand, Pfizer insists that the vaccine did reach a secondary endpoint and showed "meaningful efficacy, " and so they are moving on for regulatory approval. This puts forward a bigger question: Should healthcare systems adjust the approval processes for the situations of low incidence?

Healthcare Attention is Shifting

This development also echoes an increased worry - is the worldwide health care focus still too intent on pandemic preparation, at the risk of neglecting other new or reemerging diseases like Lyme? Lyme disease is continually getting more widespread in the US although there are very few preventive resources.

There has been no vaccine on the market since one was taken off almost 20 years ago and the call for change has become even more pressing.

Industry Stress and Market Indicators

The wavering has upset the confidence of the investors especially in the case of Valneva, the company's stock plunged considerably right after the announcement. On the other hand Pfizer with its varied product line and great profits during the pandemic period, only experienced a very small effect.

Healthcare Discussion at Large

This situation illustrates a post-COVID scenario where regulators have become more cautious, expectations for data are higher, and public trust has declined. It is likely that the Lyme vaccine trial will prove to be the deciding factor for companies in the pharmaceutical industry as to how much they are willing to prioritize intensive science against the immediate need for public health.

In a major move to enhance Texas' mental healthcare system, Governor Greg Abbott Thursday revealed a $5 million grant for the entire state to increase the training capacity in the forensic psychiatry field. One of the nine institutions that have been awarded is the University of Texas Health Science Center at Tyler which will be allocated $555,555 to support its fellowship training programs.

The money which is being handled by the Texas Higher Education Coordinating Board is intended to help produce the next group of experts in forensic psychiatry, a very important area that deals with both mental health and the law.

Expansion of Mental Healthcare Service in Texas

Governor Abbott highlighted that the grant program represents part of an overall plan to enhance mental health care service coverage throughout Texas. "These are the types of funds that will give our higher education institutions the ability not only to educate future healthcare professionals but also to increase the delivery of healthcare services to targeted communities, " he stated.

Forensic psychiatry is an indispensable component of criminal, civil, and administrative law where it is involved with conducting psychiatric assessments, preparing treatment proposals, and carrying out studies related to risk evaluation and public safety. Since the number of people seeking mental health services is on the rise, this investment by the state is targeted at solving the shortage of workers in this very specific area.

Fellowship Programs to Drive Workforce Growth

The grant award will help schools like UT Health Science Center at Tyler to create, grow, and run accredited one-year forensic psychiatry fellowship programs. These fellowships target licensed doctors who want to further their knowledge of mental health and legal systems.

Higher Education Commissioner Wynn Rosser has said several times that all the nine institutions that were picked showed great collaboration and innovation in their proposals. He explained that the initiative is part of everyone's shared vision to make Texas a national leader in forensic psychiatry education and research.

Statewide Institutional Participation

Besides that, there were other major universities getting the grants: Baylor College of Medicine, University of Texas at Austin, and University of Texas Southwestern Medical Center.

Strengthening Mental Health Systems

Focusing on forensic psychiatry fellowships, Texas is not only solving short-term problems in mental healthcare but also expanding the reach of a very necessary healthcare and justice system's field.

This well-thought-out funding is a big move towards better mental health services, legal assessments, and safer communities throughout the state.

As part of its centenary celebrations, Andhra University is set to host Pharma Innovation 2026, a national-level conclave. In fact, it is a double celebration since the Pharmacy Department also turns 75 this year. The event will be organized by the Pharmacy Council of India (PCI) and will provide a common platform for academia and industry to interact with each other.

G P Rajasekhar, the Vice Chancellor stated that the students would be made industry-ready through this conclave. He further said that the focus should primarily be on the recent developments and innovations in the pharmaceutical sector. Also, Andhra University is planning different steps for not only spreading knowledge among the students but also making them actively participate in the ever-changing industry demands for a period of five years.

Targeting Industry Readiness and Innovations

The Pharma Innovation 2026 is a conclave that will be attended by pharmaceutical experts, researchers, and students from all over the country. This will make it a major event on both academic and industry fronts. The launch of this is just in time with the increased demand of the pharma sector to merge the theoretical studies with the practical applications.

Digital Push in Student Services

The Vice Chancellor in another statement said that checking exam results of Andhra University has become fast and easy as students can now access them through the State Government's Manamitra WhatsApp service.

Cultural Hub of the Campus

From January 9th to 16th, the Andhra University Grounds not only witnessed the educational activities but also turned into a hub of cultural brightness during Sankranti Celebrations. The various spots in the area showcase the rural traditional way of living through the art of rangoli, bullock cart race, Haridasu singing, Burrakatha story-telling, and musical programs.

These celebrations, which were the brainchild of GVL Narasimha Rao, attracted an enormous number of people and at the same time brought out the rich cultural heritage of Andhra Pradesh. To celebrate Bhogi, Rao took part in the traditional ceremonies such as lighting the bonfire and praying for the prosperity and good health of everyone.

Consolidating Educational and Cultural Character

By hosting the Pharma Innovation 2026 conference along with the cultural promotions, Andhra University is not only confirming its position as a prime centre for quality education and research but also marking itself through its cultural heritage. This is the way the university is showing its adjustment as a significant contributor to the higher education and research sector in India.

India's ability to produce medical graduates has grown dramatically over the last 10 years, as per the ministry's figures shared in Rajya Sabha. There were 387 medical colleges in the country in 2014 and the number has more than doubled to 818 now.

As per information provided by the Ministry of Health and Family Welfare 11 682 MBBS seats and 8,967 postgraduates (PG) seats have been approved by the central government for the academic session 202526. Besides this, 43 additional medical colleges have been fortified nation-wide.

In a written reply in Rajya Sabha, Minister of State for Health, Anupriya Patel said the figures were forwarded to her by the National Medical Commission (NMC). The numbers represent seats both in medical colleges and in institutions such as AIIMS and other Institutes of National Importance (INIs).

Based on the data of the Ministry of Health and Family Welfare placed in Rajya Sabha, medical education in India has witnessed a major leap in capacity in the last decade. Total medical colleges in the country have touched 818 from 387 in 2014. While during this time period, UG (MBBS) seats have increased from 51,348 to 1 28 976, PG seats have also shot up from 31,185 to 85,020.

The ministry said the NMC processes applications from medical colleges every year for setting up new institutions and increasing undergraduate (UG) and postgraduate (PG) seats. Applications are submitted online and evaluated within the same academic year for which they are filed.

Assessments are carried out by the Medical Assessment and Rating Board (MARB) under the NMC. The board determines the mode of inspection before granting approval. This may include verification of digital documents, Aadhaar-based attendance records, hospital management information system (HMIS) data, photographs, video feeds, or surprise physical inspections and video conferencing.

Based on the assessment, the commission issues either a Letter of Permission (LoP) or a Letter of Disapproval (LoD) in accordance with regulations governing the establishment of medical institutions and minimum standards for UG and PG courses.

The ministry also highlighted the centrally sponsored scheme for establishing new medical colleges attached to existing district or referral hospitals, aimed particularly at underserved regions and aspirational districts. Under the scheme, 157 medical colleges have been approved in three phases with a total cost of Rs 41,332.41 crore.

Of this, the Centre’s share is Rs 26,715.84 crore, out of which Rs 23,246.10 crore has already been released, the ministry told the Rajya Sabha. The funding pattern is 90:10 between the Centre and states for northeastern and special category states, and 60:40 for other states.

The ministry added that it regularly engages with the NMC to ensure timely processing of applications and appeals related to medical seats, and that approved seat matrices are made available before the commencement of counselling.

IIT Guwahati and Coventry University have agreed to work together on AI in healthcare. This deal helps both schools share knowledge, train students, and launch joint research. They're focusing on areas where tech meets health innovation. It's a step forward for India and the UK to team up in education.

Richard Dashwood, from Coventry's research team, led the visit. He's deputy vice chancellor for research. The plan includes short term swaps for teachers and students. Plus, this helps people learn from each other. They'll also offer dual PhDs. Students can earn a degree from both schools under shared supervision. The focus is on real, world healthcare tech solutions.

It seems like this increases over time. Now, both groups can build more links in AI and medicine. Plus, they're setting a path for future joint projects. Students might find new chances to study abroad or collaborate.

The move reflects how global education is shifting. But it's still early to know how strong the partnership will become. For now, it's a solid start with clear goals.

AI for one Health is a big part of this work. It connects human, animal, and environmental health using smart tech. So this matches India's goals under the IndiaAI Mission. The plan boosts AI research, creativity, and training in the country. Officials say it will lead to new studies in digital health, smart healthcare systems, and AI tools for diagnosis. Students and researchers will get chances to work in global labs.

IIT Guwahati brings strong research skills. Coventry University adds practical knowledge and global academic links. Together, they'll create new health tech using AI. The partnership also helps grow ties between India and the UK. Results may take time. But it seems like a solid path forward.

Millions of students take NEET every year for admission to MBBS courses. But there are only a few seats allotted for NEET every year. This leads to frustration for lakhs of students whose dreams of becoming a doctor get crushed. Students often don’t know that there are several other careers in healthcare that are promising. Whether it is nursing, physiotherapy, biotechnology, or medical lab technology, there are several professional courses through which students can build a successful career in healthcare without NEET.

The evolving healthcare sector needs professionals like nurses, lab technologists, pharmacists, radiology technicians, nutritionists and public health experts. With increasing growth of hospitals, diagnostic centres, pharmacies, and health-tech startups, there is a huge scope for these professionals.

Top Medical and Healthcare Courses Without NEET

  1. BSc Nursing

Bachelor of Science in Nursing is among the most popular healthcare courses for students interested in patient care and hospital services. The four-year programme focuses on clinical training, community health, and hospital management. Graduates can work as registered nurses, ICU nurses, or public health professionals with starting salaries ranging from ₹3.6–₹6 lakh annually.

  1. Bachelor of Pharmacy (BPharm)

Bachelor of Pharmacy prepares students for careers in medicine manufacturing, testing, and pharmaceutical research. Graduates can work as pharmacists, drug inspectors, medical representatives, or clinical researchers. Entry-level salaries typically range between ₹3.5–₹6 lakh per year.

  1. Bachelor of Physiotherapy (BPT)

Bachelor of Physiotherapy is ideal for students interested in rehabilitation and physical therapy. The 4–4.5 year course trains students to treat injuries and mobility disorders. Career options include sports physiotherapist, rehabilitation expert, or clinical physiotherapist, with salaries ranging from ₹3–₹7 lakh annually.

  1. BSc Medical Laboratory Technology

Bachelor of Science in Medical Laboratory Technology focuses on diagnostic procedures such as blood and urine tests. Lab technologists play a crucial role in disease diagnosis and treatment planning. The course duration is three years and salaries can range from ₹4.5–₹6.5 lakh annually.

  1. BSc Radiology and Imaging Technology

Bachelor of Science in Radiology and Imaging Technology trains students in imaging techniques like X-rays, CT scans, and MRI. Radiology technologists are highly sought after in hospitals and diagnostic centres, earning between ₹4–₹10 lakh per year.

  1. BSc Nutrition and Dietetics

Bachelor of Science in Nutrition and Dietetics focuses on health, diet planning, and disease prevention through nutrition. Graduates can work as nutritionists, dietitians, or health coaches, earning ₹3.5–₹7.5 lakh annually.

  1. BSc Biotechnology and Biomedical Science

Courses like Bachelor of Science in Biotechnology and Biomedical Science open opportunities in pharmaceutical research, medical technology, and clinical trials. Graduates often work as research assistants, scientists, or clinical research associates.

An Increasing Workforce in Healthcare Industry

Health awareness, better technology and equipment, and increasing healthcare infrastructure are helping the allied medical professions demand trained workforce. These courses offer wonderful career opportunities to non-Neff students who wish to work in a fulfilling and well-paying job in the medical and healthcare industry.

A 23-year-old woman was diagnosed with a panic attack following an earthquake scare, according to a medical prescription dated February 27, 2026.

The prescription, issued by Dr. Sumit Saha, a consultant physician and neuropsychiatrist, records the patient’s name as Arpita Dey, aged 23. The diagnosis noted on the document states “Panic attack following earthquake.”

A reading taken during the check showed the heart beating 122 times each minute, though values might shift slightly on repeat tests. Blood pressure stood at 110 over 80 millimeters of mercury when recorded by hand. Oxygen levels reached full capacity, no shortage detected in circulation. When pulses climb like this, experts often link it to sudden emotional strain rather than physical illness. One clue could lie in how tense the person felt right before measurements.

A pill for anxiety shows up on the list, Zapiz at 0.25 mg, followed by Panazep LS or Paxonil Plus LS instead of it sometimes, plus capsules called Pazop DSR mixed in. Two weeks later, a check in makes sense. Some lab work got flagged too, needed down the line.

How natural disasters affect mental health

Folks who study minds say quakes smash buildings, yet also mess with thoughts just as much. Out of nowhere, a jolt like that might spark panic, even if someone never felt anxious before.

A sudden shake might stop, yet minds keep feeling it, so says Dr. Amit Dias, a psychiatrist based in Goa.

“Earthquakes do not end when the tremors stop. For many survivors, the psychological aftershocks continue for months or even years. It is common for people to experience anxiety, sleep disturbances, fear of entering buildings, and in some cases Post, Traumatic Stress Disorder (PTSD), he said.

It turns out some folks carry invisible scars long after disaster strikes. One report showed up to one in five people might struggle months later. Trauma tends to stick around when bodies are hurt, connections broken, or homes lost. The deeper the shock, the heavier the mental load often becomes.

However, Dr. Dias emphasised that most stress reactions are normal and tend to improve with time and social support. Early psychological first aid, community support systems, access to counselling, and timely mental health care can prevent long, term complications. Recognising distress early and seeking help without stigma is crucial. Disaster response must address not only physical safety, but emotional recovery as well, he said.

Finding yourself anxious, heart racing, passing out, or struggling to sleep following a trauma? Doctors suggest reaching out for help without delay. Talking to someone trained might make things clearer. A checkup could rule out physical causes. Support comes in many forms, not just pills. Sometimes simply sharing what happened shifts something inside. Getting care early often eases longer, term strain. The body holds onto stress in surprising ways. Night after night of broken rest takes its toll. Moments of panic can feel endless when alone. Professional guidance isnt about fixing fast, its about understanding better. Help exists because healing rarely travels straight lines.

More Articles ...